Minaris Regenerative Medicine is a leading Contract Development and Manufacturing Organisation (CDMO) specialising in cell and gene therapies. With over 25 years of expertise, the company supports the clinical and commercial manufacturing of innovative treatments across its global facilities.

Minaris Regenerative Medicine offers a full range of services, including process development, GMP manufacturing, and comprehensive analytical services. The company operates facilities in the US, Europe, and Japan, with a commitment to advancing cell therapy technologies and creating transformative solutions for patients worldwide.

Key Products and Services

• Development of robust manufacturing processes for cell and gene therapies
• GMP-compliant manufacturing services
• Sterility testing and quality control
• Technology transfer and consulting
• Support for over 180 clients in the biopharmaceutical industry

Minaris Regenerative Medicine continues to drive advancements in cell and gene therapy, partnering with companies to deliver high-quality, scalable solutions that push the boundaries of medical science.